Literature DB >> 28588436

Novel Marfan Syndrome-Associated Mutation in the FBN1 Gene Caused by Parental Mosaicism and Leading to Abnormal Limb Patterning.

Efrén Martínez-Quintana1, Noemí Caballero-Sánchez2, Fayna Rodríguez-González3, Paloma Garay-Sánchez2, Antonio Tugores2.   

Abstract

Marfan syndrome is an autosomal dominant disorder of the connective tissue caused by mutations in the fibrillin-1 (FBN1) gene. Mutations affecting cysteine residues within the epidermal growith factor-like calcium-binding domains (EGF_CA) of FBN1 are associated with Marfan syndrome features and, especially, with ectopia lentis. We report a novel substitution, affecting the first cysteine of an EGF_CA-binding module encoded by exon 63 of FBN1 (C2571Y), in a patient presenting with typical Marfan syndrome features but without ectopia lentis. The involvement of this particular carboxi-terminal domain in bone morphogenetic protein signaling is evidenced by patterning defects in the apendicular skeleton shown by the gain of a phalange at digit 1 and the fusion of some wrist bones. Although the mutation appeared as sporadic, detailed analysis revealed that the asymptomatic father was a gonosomal mosaic, and that aproximately 25% of his body cells carry the mutation. Based on this and previous evidence on the origin of sporadic mutations, we would like to stress the importance of detailed parental genetic screening, so the risk of recurrence may be evaluated.

Entities:  

Keywords:  Bone morphogenetic protein; Cysteine; EGF_CA domain; Marfan syndrome; Mosaicism; Patterning

Year:  2017        PMID: 28588436      PMCID: PMC5448450          DOI: 10.1159/000467909

Source DB:  PubMed          Journal:  Mol Syndromol        ISSN: 1661-8769


  27 in total

Review 1.  Marfan's syndrome.

Authors:  Daniel P Judge; Harry C Dietz
Journal:  Lancet       Date:  2005-12-03       Impact factor: 79.321

2.  Cysteine substitutions in epidermal growth factor-like domains of fibrillin-1: distinct effects on biochemical and clinical phenotypes.

Authors:  I Schrijver; W Liu; T Brenn; H Furthmayr; U Francke
Journal:  Am J Hum Genet       Date:  1999-10       Impact factor: 11.025

3.  CDD: NCBI's conserved domain database.

Authors:  Aron Marchler-Bauer; Myra K Derbyshire; Noreen R Gonzales; Shennan Lu; Farideh Chitsaz; Lewis Y Geer; Renata C Geer; Jane He; Marc Gwadz; David I Hurwitz; Christopher J Lanczycki; Fu Lu; Gabriele H Marchler; James S Song; Narmada Thanki; Zhouxi Wang; Roxanne A Yamashita; Dachuan Zhang; Chanjuan Zheng; Stephen H Bryant
Journal:  Nucleic Acids Res       Date:  2014-11-20       Impact factor: 16.971

4.  Identification of sixty-two novel and twelve known FBN1 mutations in eighty-one unrelated probands with Marfan syndrome and other fibrillinopathies.

Authors:  Eloisa Arbustini; Maurizia Grasso; Silvia Ansaldi; Clara Malattia; Andrea Pilotto; Emanuele Porcu; Eliana Disabella; Nicola Marziliano; Angela Pisani; Luca Lanzarini; Savina Mannarino; Daniela Larizza; Mario Mosconi; Elena Antoniazzi; M Cristina Zoia; Giulia Meloni; Lorenzo Magrassi; Agnese Brega; Maria Francesca Bedeschi; Isabella Torrente; Francesca Mari; Luigi Tavazzi
Journal:  Hum Mutat       Date:  2005-11       Impact factor: 4.878

Review 5.  Update of the UMD-FBN1 mutation database and creation of an FBN1 polymorphism database.

Authors:  Gwenaëlle Collod-Béroud; Saga Le Bourdelles; Lesley Ades; Leena Ala-Kokko; Patrick Booms; Maureen Boxer; Anne Child; Paolo Comeglio; Anne De Paepe; James C Hyland; Katerine Holman; Ilkka Kaitila; Bart Loeys; Gabor Matyas; Lieve Nuytinck; Leena Peltonen; Terhi Rantamaki; Peter Robinson; Beat Steinmann; Claudine Junien; Christophe Béroud; Catherine Boileau
Journal:  Hum Mutat       Date:  2003-09       Impact factor: 4.878

6.  Targeting of bone morphogenetic protein growth factor complexes to fibrillin.

Authors:  Gerhard Sengle; Noe L Charbonneau; Robert N Ono; Takako Sasaki; Jennifer Alvarez; Douglas R Keene; Hans Peter Bächinger; Lynn Y Sakai
Journal:  J Biol Chem       Date:  2008-03-13       Impact factor: 5.157

7.  Effect of mutation type and location on clinical outcome in 1,013 probands with Marfan syndrome or related phenotypes and FBN1 mutations: an international study.

Authors:  L Faivre; G Collod-Beroud; B L Loeys; A Child; C Binquet; E Gautier; B Callewaert; E Arbustini; K Mayer; M Arslan-Kirchner; A Kiotsekoglou; P Comeglio; N Marziliano; H C Dietz; D Halliday; C Beroud; C Bonithon-Kopp; M Claustres; C Muti; H Plauchu; P N Robinson; L C Adès; A Biggin; B Benetts; M Brett; K J Holman; J De Backer; P Coucke; U Francke; A De Paepe; G Jondeau; C Boileau
Journal:  Am J Hum Genet       Date:  2007-07-25       Impact factor: 11.025

Review 8.  Vertebrate limb development: moving from classical morphogen gradients to an integrated 4-dimensional patterning system.

Authors:  Jean-Denis Bénazet; Rolf Zeller
Journal:  Cold Spring Harb Perspect Biol       Date:  2009-10       Impact factor: 10.005

9.  Novel FBN1 gene mutation and maternal germinal mosaicism as the cause of neonatal form of Marfan syndrome.

Authors:  Antonín Sípek; Lucie Grodecká; Alice Baxová; Petra Cibulková; Magdaléna Dvořáková; Stella Mazurová; Martin Magner; Jiří Zeman; Tomáš Honzík; Tomáš Freiberger
Journal:  Am J Med Genet A       Date:  2014-03-25       Impact factor: 2.802

10.  Fibrillin-1 and -2 differentially modulate endogenous TGF-β and BMP bioavailability during bone formation.

Authors:  Harikiran Nistala; Sui Lee-Arteaga; Silvia Smaldone; Gabriella Siciliano; Luca Carta; Robert N Ono; Gerhard Sengle; Emilio Arteaga-Solis; Regis Levasseur; Patricia Ducy; Lynn Y Sakai; Gerard Karsenty; Francesco Ramirez
Journal:  J Cell Biol       Date:  2010-09-20       Impact factor: 10.539

View more
  3 in total

1.  NGS analysis in Marfan syndrome spectrum: Combination of rare and common genetic variants to improve genotype-phenotype correlation analysis.

Authors:  Davide Gentilini; Antonino Oliveri; Teresa Fazia; Alessandro Pini; Susan Marelli; Luisa Bernardinelli; Anna Maria Di Blasio
Journal:  PLoS One       Date:  2019-09-19       Impact factor: 3.240

2.  Parental mosaicism in Marfan and Ehlers-Danlos syndromes and related disorders.

Authors:  Bertrand Chesneau; Aurélie Plancke; Guillaume Rolland; Nicolas Chassaing; Christine Coubes; Elise Brischoux-Boucher; Thomas Edouard; Yves Dulac; Marion Aubert-Mucca; Thierry Lavabre-Bertrand; Julie Plaisancié; Philippe Khau Van Kien
Journal:  Eur J Hum Genet       Date:  2021-01-07       Impact factor: 5.351

3.  Gonosomal Mosaicism for a Novel COL5A1 Pathogenic Variant in Classic Ehlers-Danlos Syndrome.

Authors:  Lucia Micale; Thomas Foiadelli; Federica Russo; Luigia Cinque; Francesco Bassanese; Matteo Granatiero; Carmela Fusco; Salvatore Savasta; Marco Castori
Journal:  Genes (Basel)       Date:  2021-11-29       Impact factor: 4.096

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.